Nrf2 activator for the treatment of kidney diseases
Author:
Funder
Kyowa Hakko Kirin
Publisher
Elsevier BV
Subject
Pharmacology,Toxicology
Reference74 articles.
1. Effect of a carbonaceous oral adsorbent on the progression of CKD: a multicenter, randomized, controlled trial;Akizawa;Am. J. Kidney Dis.,2009
2. Transcriptional regulation of renal cytoprotective genes by Nrf2 and its potential use as a therapeutic target to mitigate cisplatin-induced nephrotoxicity;Aleksunes;J. Pharmacol. Exp. Ther.,2010
3. Curcumin ameliorates kidney function and oxidative stress in experimental chronic kidney disease;Ali;Basic Clin. Pharmacol. Toxicol.,2018
4. The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores endothelial function impaired by reduced Nrf2 activity in chronic kidney disease;Aminzadeh;Redox Biol.,2013
5. The Synthetic Triterpenoid RTA dh404 (CDDO-dhTFEA) Restores Nrf2 Activity and Attenuates Oxidative Stress, Inflammation, and Fibrosis in Rats with Chronic Kidney Disease. Xenobiotica; the Fate of Foreign Compounds in Biological Systems;Aminzadeh,2014
Cited by 51 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Salinomycin, a potent inhibitor of XOD and URAT1, ameliorates hyperuricemic nephropathy by activating NRF2, modulating the gut microbiota, and promoting SCFA production;Chemico-Biological Interactions;2024-11
2. The main molecular mechanisms of ferroptosis and its role in chronic kidney disease;Cellular Signalling;2024-09
3. Ocotillol Derivatives Mitigate Retinal Ischemia-Reperfusion Injury by Regulating the Keap1/Nrf2/ARE Signaling Pathway;Journal of Medicinal Chemistry;2024-08-15
4. Activation of the Nrf2/ARE signaling pathway ameliorates hyperlipidemia-induced renal tubular epithelial cell injury by inhibiting mtROS-mediated NLRP3 inflammasome activation;Frontiers in Immunology;2024-04-24
5. Exploration of Diagnostic Markers Associated with Inflammation in Chronic Kidney Disease Based on WGCNA and Machine Learning;Critical Reviews in Immunology;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3